Borderline personality disorder and bone marrow transplantation: ethical considerations and review.
Bone marrow transplantation (BMT) is rapidly becoming a part of conventional cancer treatment. However, it remains a 'last-ditch' treatment option for patients who have exhausted other treatment modalities. Patients experience a significant amount of emotional distress during all stages of the BMT process. Patients with personality disorders experience even more emotional distress than average and their behavior is often detrimental to effective patient-staff interactions. A case of a borderline patient is presented with a discussion of the ethical issues involved in the evaluation of these patients and the determination of their appropriateness for transplant.
Weitzner
M A
MA
Psychosocial Oncology Program, H. Lee Moffitt Cancer Center, Tampa, Florida 33612-9497, USA. weitznma@moffitt.usf.edu
Lehninger
F
F
Sullivan
D
D
Fields
K K
KK
D000223:Adaptation, Psychological; D000328:Adult; D016026:Bone Marrow Transplantation / Q000523:psychology*; D001883:Borderline Personality Disorder / Q000523:psychology*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D018579:Patient Selection; D013315:Stress, Psychological